Negative Pressure Wound Therapy vs Standard Care Dressing (Prevena)

May 18, 2024 updated by: Munier Nazzal, M.S. M.D, University of Toledo Health Science Campus

A Comparison of Negative Pressure Wound Therapy vs Standard Care, for Vascular, Plastic and General Surgery

A comparison between the efficacy of negative pressure wound therapy and the efficacy of standard care dressing

Study Overview

Detailed Description

The aim of our study is to compare the efficacy of negative pressure wound therapy (Prevena) and standard clinical dressing in terms of prevention of postoperative surgical site infection, length of hospital stay, and total cost of hospitalization among vascular, plastic and general surgery patients.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 86 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Consent for participation from the patient or his legal representative

Exclusion Criteria:

  • Currently infected wounds
  • Patients with history of immunosupression
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Negative pressure wound therapy
This group of patients will receive negative pressure wound therapy (prevena) as their postoperative wound care method.
The application of a vacuum across the surface of a wound through a foam dressing cut to fit the wound.
Other Names:
  • Prevena
Active Comparator: standard care dressing
This group of patients will receive standard care dressing as their postoperative wound care method.
The application of a standard care dressing (instead of negative pressure wound therapy) across the surface of wound.
Other Names:
  • dray gauze

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surgical site infection
Time Frame: 30-day postoperative period
The rate of occurrence of signs and symptoms of surgical site infection
30-day postoperative period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
length of total hospital stay
Time Frame: 6 months
number of days of patients hospital stay after the surgery
6 months
cost of hospitalization
Time Frame: 6 months
The total cost in USD of patient's hospitalization
6 months
Rate of reoperation
Time Frame: 30-day postoperative period
The rate of patients' re-operation after the principal operation
30-day postoperative period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: munier nazzal, md, UTMC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 28, 2018

Primary Completion (Actual)

April 1, 2019

Study Completion (Actual)

April 15, 2019

Study Registration Dates

First Submitted

April 25, 2018

First Submitted That Met QC Criteria

June 20, 2018

First Posted (Actual)

June 25, 2018

Study Record Updates

Last Update Posted (Actual)

May 21, 2024

Last Update Submitted That Met QC Criteria

May 18, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Prevena V. 11/14/17

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Negative-Pressure Wound Therapy

Clinical Trials on Negative pressure wound therapy

Subscribe